Novel Hydrogel: Targeted Delivery of Drugs for Rheumatoid Arthritis Patients

News   Oct 12, 2017 | Original story from the Institute for Basic Research

 
Novel Hydrogel: Targeted Delivery of Drugs for Rheumatoid Arthritis Patients

IBS scientists developed a hydrogel made of polymeric acrylamide (blue spaghetti) linked with crosslinkers (black), which can accommodate drug molecules (purple stars) within its mesh (grey). In the presence of nitric oxide (red), the linker is cleaved and the drug molecules can be released. At the same time, the gel absorbs fluid from the surroundings and swells in size. Image credit: Park J. et al, Advanced Materials (2017)

 
 
 

RELATED ARTICLES

Bogong Moths Use Magnetic Fields to Navigate

News

have found that the moths, like migratory birds, depend on the Earth's magnetic field to guide them on their way.

READ MORE

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.

READ MORE

Simple Sugar Prevents Neurodegeneration in Lysosomal Storage Disease

News

New therapeutic approach may one day delay neurodegeneration typical of a disease called mucopolysaccharidoses IIIB (MPS IIIB)

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy